RNWBX
Price
$80.94
Change
+$0.59 (+0.73%)
Updated
Jun 2 closing price
Net Assets
66.97B
RREMX
Price
$14.60
Change
+$0.12 (+0.83%)
Updated
Jun 2 closing price
Net Assets
4.42B
Interact to see
Advertisement

RNWBX vs RREMX

Header iconRNWBX vs RREMX Comparison
Open Charts RNWBX vs RREMXBanner chart's image
American Funds New World R2
Price$80.94
Change+$0.59 (+0.73%)
VolumeN/A
Net Assets66.97B
RBC Emerging Markets Equity R6
Price$14.60
Change+$0.12 (+0.83%)
VolumeN/A
Net Assets4.42B
RNWBX vs RREMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWBX vs. RREMX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWBX is a Buy and RREMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 67B vs. RREMX (4.42B). RREMX pays higher dividends than RNWBX: RREMX (0.85) vs RNWBX (0.13). RNWBX was incepted earlier than RREMX: RNWBX (23 years) vs RREMX (9 years). RNWBX (1.67) is less costly to investors than RREMX (0.88). RNWBX is a more actively managed with annual turnover of: 37.00 vs. RREMX (34.00). RNWBX has a lower initial minimum investment than RREMX: RNWBX (250) vs RREMX (250000). RREMX annual gain was more profitable for investors over the last year : 12.07 vs. RNWBX (6.23). RREMX return over 5 years is better than : 35.62 vs. RNWBX (24.70).
RNWBXRREMXRNWBX / RREMX
Total Expense Ratio1.670.88190%
Annual Report Gross Expense Ratio1.670.88190%
Fund Existence23 years9 years-
Gain YTD9.2459.86394%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets67B4.42B1,515%
Annual Yield % from dividends0.130.8516%
Returns for 1 year6.2312.0752%
Returns for 3 years19.9025.4178%
Returns for 5 years24.7035.6269%
Returns for 10 years51.61N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVURX7.84N/A
N/A
American Century Value R
SSDIX33.18N/A
N/A
DWS Small Cap Growth Inst
JGECX12.25N/A
N/A
JHancock Global Equity C
THISX74.49N/A
N/A
T. Rowe Price Health Sciences I
FCGPX19.72N/A
N/A
NYLI PineStone Global Equity Class P